Prévalence des effets indésirables de l’hydroxychloroquine (Plaquenil®) dans une population dermatologique : étude rétrospective sur 102 patients
Pauline Tétu(Inserm), François Chasset(Sorbonne Université), A. Barbaud(Centre Hospitalier Régional et Universitaire de Nancy), Bénédicte Lebrun‐Vignes(Sorbonne Université), A. Hamelin(Sorbonne Université), A. Soria(Inserm), C. Françès(Navarre Institute of Health Research)
Cited by 20
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Skin Thickness Changes in Normal Aging Skin
|Gerontology|2009|258
Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients
|Annals of the Rheumatic Diseases|2007|235